Pelliccia Antonio, Maron Barry J, Di Paolo Fernando M, Biffi Alessandro, Quattrini Filippo M, Pisicchio Cataldo, Roselli Alessandra, Caselli Stefano, Culasso Franco
National Institute of Sports Medicine, Italian National Olympic Committee, Rome, Italy.
J Am Coll Cardiol. 2005 Aug 16;46(4):690-6. doi: 10.1016/j.jacc.2005.04.052.
In the present study we assessed the distribution and clinical significance of left atrial (LA) size in the context of athlete's heart and the differential diagnosis from structural heart disease, as well as the proclivity to supraventricular arrhythmias.
The prevalence, clinical significance, and long-term arrhythmic consequences of LA enlargement in competitive athletes are unresolved.
We assessed LA dimension and the prevalence of supraventricular tachyarrhythmias in 1,777 competitive athletes (71% of whom were males), free of structural cardiovascular disease, that were participating in 38 different sports.
The LA dimension was 23 to 50 mm (mean, 37 +/- 4 mm) in men and 20 to 46 mm (mean, 32 +/- 4 mm) in women and was enlarged (i.e., transverse dimension > or = 40 mm) in 347 athletes (20%), including 38 (2%) with marked dilation (> or = 45 mm). Of the 1,777 athletes, only 14 (0.8%) had documented, symptomatic episodes of either paroxysmal atrial fibrillation (n = 5; 0.3%) or supraventricular tachycardia (n = 9; 0.5%), which together occurred in a similar proportion in athletes with (0.9%) or without (0.8%; p = NS) LA enlargement. Multivariate regression analysis showed LA enlargement in athletes was largely explained by left ventricular cavity enlargement (R2 = 0.53) and participation in dynamic sports (such as cycling, rowing/canoeing) but minimally by body size.
In a large population of highly trained athletes, enlarged LA dimension > or = 40 mm was relatively common (20%), with the upper limits of 45 mm in women and 50 mm in men distinguishing physiologic cardiac remodeling ("athlete's heart") from pathologic cardiac conditions. Atrial fibrillation and other supraventricular tachyarrhythmias proved to be uncommon (prevalence < 1%) and similar to that in the general population, despite the frequency of LA enlargement. Left atrial remodeling in competitive athletes may be regarded as a physiologic adaptation to exercise conditioning, largely without adverse clinical consequences.
在本研究中,我们评估了运动员心脏背景下左心房(LA)大小的分布及其临床意义,以及与结构性心脏病的鉴别诊断,还有室上性心律失常的倾向。
竞技运动员左心房扩大的患病率、临床意义及长期心律失常后果尚无定论。
我们评估了1777名无结构性心血管疾病、参加38项不同运动的竞技运动员的左心房尺寸及室上性快速心律失常的患病率(其中71%为男性)。
男性左心房尺寸为23至50毫米(平均37±4毫米),女性为20至46毫米(平均32±4毫米),347名运动员(20%)左心房扩大(即横向尺寸≥40毫米),其中38名(2%)有明显扩张(≥45毫米)。在1777名运动员中,只有14名(0.8%)有记录在案的阵发性心房颤动(n = 5;0.3%)或室上性心动过速(n = 9;0.5%)的症状性发作,在左心房扩大的运动员(0.9%)和未扩大的运动员(0.8%;p = 无显著性差异)中发生率相似。多变量回归分析显示,运动员左心房扩大在很大程度上由左心室腔扩大(R2 = 0.53)和参与动态运动(如骑自行车、赛艇/皮划艇)所致,而与体型关系最小。
在大量训练有素的运动员中,左心房尺寸≥40毫米相对常见(20%),女性上限为45毫米,男性为50毫米,可区分生理性心脏重塑(“运动员心脏”)与病理性心脏状况。心房颤动和其他室上性快速心律失常并不常见(患病率<1%),与普通人群相似,尽管左心房扩大较为频繁。竞技运动员的左心房重塑可视为对运动训练的生理性适应,基本无不良临床后果。